Embryonal carcinoma cells
P19 embryonal carcinoma cells
6
Polyomavirus enhancer requirements for expression in embryonal carcinoma cells
9
The Thy 1 glycoprotein is expressed in mouse embryonal carcinoma cells P19
10
Differential expression of the mouse and human Thy 1 gene in embryonal carcinoma cells
5
Changes in surface glycoconjugates in adhesion defective variants of P19 embryonal carcinoma cells
7
Type beta transforming growth factors and activins in differentiating embryonal carcinoma cells, embryonic stem cells and early embryonic development
14
Cytotoxicity Evaluation of Methanol Extracts of Some Medicinal Plants on P19 Embryonal Carcinoma Cells
8
Negative regulation of retrovirus expression in embryonal carcinoma cells mediated by an intragenic domain.
10
Regulation of polyoma virus transcription in murine embryonal carcinoma cells.
10
Control of transcription in embryonal carcinoma cells
321
Melatonin antiproliferative effects require active mitochondrial function in embryonal carcinoma cells
16
Unique requirement for the PyF441 mutation for polyomavirus infection of F9 embryonal carcinoma cells.
7
Bone morphogenetic proteins (BMPs) induce epithelial differentiation of NT2D1 human embryonal carcinoma cells
8
Retroviral vector gene expression in F9 embryonal carcinoma cells.
6
Isolation of polyomavirus mutants multiadapted to murine embryonal carcinoma cells.
5
Capture of a cellular transcriptional unit by a retrovirus: mode of provirus activation in embryonal carcinoma cells.
10
Increased probability of expression from modified retroviral vectors in embryonal stem cells and embryonal carcinoma cells.
9
Determinants of retrovirus gene expression in embryonal carcinoma cells.
7
Biological activities of oligonucleotides spanning the F9 point mutation within the enhancer region of polyomavirus DNA.
8
A mutational analysis of the regulation of retroviral transcription in embryonic stem cells
335